ArticlePharmaceutical statistics2021

Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology.

Robin Ristl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.